FDA inspection

Bioreliance Ltd.: FDA inspection ending Jun 30, 2022

FDA inspection 1202973 · Voluntary Action Indicated (VAI) · Stirling, Scotland

Key facts

Inspection ID 1202973
Firm Bioreliance Ltd.
FEI number 3005619549
Address Scotland, Hillfoots Road; Innovation Park
City Stirling, Scotland
Country United Kingdom
Fiscal year 2022
Inspection end date Jun 30, 2022
Classification Voluntary Action Indicated (VAI)
Project area Drug Quality Assurance
Product type Drugs

At a glance

  • None Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections